Alert: Rating Downgrade (12/15/23)-Acadia Pharmaceuticals Inc (NASDAQ: ACAD).
Stock Rating Downgrade In the last week the Value Trend Rating for Acadia Pharmaceuticals Inc (NASDAQ: ACAD) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Acadia Pharmaceuticals Inc […]